nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT1A1—Irinotecan—colon cancer	0.147	0.204	CbGbCtD
Fluvastatin—SLCO1B1—Irinotecan—colon cancer	0.102	0.141	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—colon cancer	0.0923	0.129	CbGbCtD
Fluvastatin—CYP2B6—Irinotecan—colon cancer	0.0568	0.079	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—colon cancer	0.0538	0.0749	CbGbCtD
Fluvastatin—CYP2C9—Capecitabine—colon cancer	0.0486	0.0676	CbGbCtD
Fluvastatin—CYP3A5—Irinotecan—colon cancer	0.0447	0.0623	CbGbCtD
Fluvastatin—CYP2C8—Fluorouracil—colon cancer	0.0413	0.0574	CbGbCtD
Fluvastatin—CYP3A5—Vincristine—colon cancer	0.0391	0.0544	CbGbCtD
Fluvastatin—CYP1A2—Fluorouracil—colon cancer	0.0319	0.0445	CbGbCtD
Fluvastatin—CYP2C9—Fluorouracil—colon cancer	0.0288	0.0401	CbGbCtD
Fluvastatin—CYP3A4—Irinotecan—colon cancer	0.0174	0.0243	CbGbCtD
Fluvastatin—CYP3A4—Vincristine—colon cancer	0.0152	0.0212	CbGbCtD
Fluvastatin—HMGCR—gall bladder—colon cancer	0.00343	0.0491	CbGeAlD
Fluvastatin—UGT1A3—digestive system—colon cancer	0.00318	0.0456	CbGeAlD
Fluvastatin—UGT1A3—liver—colon cancer	0.00237	0.0339	CbGeAlD
Fluvastatin—UGT2B7—renal system—colon cancer	0.00223	0.0319	CbGeAlD
Fluvastatin—SLCO1B3—vagina—colon cancer	0.00198	0.0283	CbGeAlD
Fluvastatin—UGT1A1—renal system—colon cancer	0.0019	0.0271	CbGeAlD
Fluvastatin—SLC15A1—epithelium—colon cancer	0.00184	0.0263	CbGeAlD
Fluvastatin—UGT2B7—digestive system—colon cancer	0.00183	0.0262	CbGeAlD
Fluvastatin—HMGCR—epithelium—colon cancer	0.00178	0.0254	CbGeAlD
Fluvastatin—HMGCR—smooth muscle tissue—colon cancer	0.00171	0.0245	CbGeAlD
Fluvastatin—SLC15A1—renal system—colon cancer	0.0017	0.0244	CbGeAlD
Fluvastatin—SLCO1B3—liver—colon cancer	0.00167	0.0238	CbGeAlD
Fluvastatin—HMGCR—renal system—colon cancer	0.00165	0.0236	CbGeAlD
Fluvastatin—SLCO1B1—renal system—colon cancer	0.00158	0.0226	CbGeAlD
Fluvastatin—UGT1A1—digestive system—colon cancer	0.00155	0.0222	CbGeAlD
Fluvastatin—SLC15A1—digestive system—colon cancer	0.0014	0.02	CbGeAlD
Fluvastatin—SLCO2B1—renal system—colon cancer	0.0014	0.02	CbGeAlD
Fluvastatin—HMGCR—lymphoid tissue—colon cancer	0.00137	0.0196	CbGeAlD
Fluvastatin—UGT2B7—liver—colon cancer	0.00136	0.0195	CbGeAlD
Fluvastatin—HMGCR—digestive system—colon cancer	0.00135	0.0193	CbGeAlD
Fluvastatin—SLCO1B1—digestive system—colon cancer	0.00129	0.0185	CbGeAlD
Fluvastatin—Pitavastatin—ABCB1—colon cancer	0.00129	0.554	CrCbGaD
Fluvastatin—HMGCR—bone marrow—colon cancer	0.00124	0.0178	CbGeAlD
Fluvastatin—SLC15A1—vagina—colon cancer	0.00123	0.0177	CbGeAlD
Fluvastatin—HMGCR—vagina—colon cancer	0.00119	0.0171	CbGeAlD
Fluvastatin—UGT1A1—liver—colon cancer	0.00116	0.0166	CbGeAlD
Fluvastatin—SLCO2B1—digestive system—colon cancer	0.00114	0.0164	CbGeAlD
Fluvastatin—SLC15A1—liver—colon cancer	0.00104	0.0149	CbGeAlD
Fluvastatin—Atorvastatin—ABCB1—colon cancer	0.00104	0.446	CrCbGaD
Fluvastatin—HMGCR—liver—colon cancer	0.00101	0.0144	CbGeAlD
Fluvastatin—SLCO1B1—liver—colon cancer	0.000964	0.0138	CbGeAlD
Fluvastatin—CYP2C8—renal system—colon cancer	0.000897	0.0128	CbGeAlD
Fluvastatin—CYP1A1—epithelium—colon cancer	0.000893	0.0128	CbGeAlD
Fluvastatin—SLCO2B1—liver—colon cancer	0.000852	0.0122	CbGeAlD
Fluvastatin—CYP2C19—digestive system—colon cancer	0.000843	0.0121	CbGeAlD
Fluvastatin—CYP1A2—renal system—colon cancer	0.000839	0.012	CbGeAlD
Fluvastatin—CYP1A1—renal system—colon cancer	0.000828	0.0118	CbGeAlD
Fluvastatin—CYP3A5—renal system—colon cancer	0.00081	0.0116	CbGeAlD
Fluvastatin—CYP2B6—renal system—colon cancer	0.000805	0.0115	CbGeAlD
Fluvastatin—HMGCR—lymph node—colon cancer	0.000771	0.011	CbGeAlD
Fluvastatin—CYP2C19—vagina—colon cancer	0.000744	0.0107	CbGeAlD
Fluvastatin—CYP1A2—digestive system—colon cancer	0.000688	0.00985	CbGeAlD
Fluvastatin—CYP1A1—digestive system—colon cancer	0.000679	0.00972	CbGeAlD
Fluvastatin—CYP2B6—lymphoid tissue—colon cancer	0.000668	0.00956	CbGeAlD
Fluvastatin—CYP3A5—digestive system—colon cancer	0.000664	0.0095	CbGeAlD
Fluvastatin—CYP2B6—digestive system—colon cancer	0.00066	0.00944	CbGeAlD
Fluvastatin—SLCO2B1—lymph node—colon cancer	0.000654	0.00935	CbGeAlD
Fluvastatin—CYP2C9—digestive system—colon cancer	0.000653	0.00935	CbGeAlD
Fluvastatin—CYP2C8—vagina—colon cancer	0.00065	0.0093	CbGeAlD
Fluvastatin—CYP2C19—liver—colon cancer	0.000628	0.00898	CbGeAlD
Fluvastatin—CYP3A4—renal system—colon cancer	0.000608	0.00869	CbGeAlD
Fluvastatin—CYP1A1—vagina—colon cancer	0.0006	0.00858	CbGeAlD
Fluvastatin—CYP2D6—renal system—colon cancer	0.000598	0.00855	CbGeAlD
Fluvastatin—CYP3A5—vagina—colon cancer	0.000586	0.00839	CbGeAlD
Fluvastatin—CYP2B6—vagina—colon cancer	0.000583	0.00834	CbGeAlD
Fluvastatin—CYP2C8—liver—colon cancer	0.000548	0.00784	CbGeAlD
Fluvastatin—Photosensitivity—Methotrexate—colon cancer	0.000517	0.00307	CcSEcCtD
Fluvastatin—CYP1A2—liver—colon cancer	0.000513	0.00734	CbGeAlD
Fluvastatin—Ill-defined disorder—Irinotecan—colon cancer	0.000509	0.00303	CcSEcCtD
Fluvastatin—Bronchitis—Capecitabine—colon cancer	0.000507	0.00301	CcSEcCtD
Fluvastatin—Vertigo—Vincristine—colon cancer	0.000506	0.00301	CcSEcCtD
Fluvastatin—CYP1A1—liver—colon cancer	0.000506	0.00724	CbGeAlD
Fluvastatin—Hepatic failure—Methotrexate—colon cancer	0.000505	0.003	CcSEcCtD
Fluvastatin—Leukopenia—Vincristine—colon cancer	0.000504	0.003	CcSEcCtD
Fluvastatin—CYP3A4—digestive system—colon cancer	0.000498	0.00713	CbGeAlD
Fluvastatin—Malaise—Irinotecan—colon cancer	0.000495	0.00294	CcSEcCtD
Fluvastatin—CYP3A5—liver—colon cancer	0.000495	0.00708	CbGeAlD
Fluvastatin—Vertigo—Irinotecan—colon cancer	0.000493	0.00293	CcSEcCtD
Fluvastatin—Syncope—Irinotecan—colon cancer	0.000492	0.00293	CcSEcCtD
Fluvastatin—Renal failure acute—Methotrexate—colon cancer	0.000492	0.00292	CcSEcCtD
Fluvastatin—CYP2B6—liver—colon cancer	0.000492	0.00703	CbGeAlD
Fluvastatin—Leukopenia—Irinotecan—colon cancer	0.000491	0.00292	CcSEcCtD
Fluvastatin—CYP2D6—digestive system—colon cancer	0.00049	0.00702	CbGeAlD
Fluvastatin—Upper respiratory tract infection—Capecitabine—colon cancer	0.00049	0.00291	CcSEcCtD
Fluvastatin—CYP2C9—liver—colon cancer	0.000487	0.00697	CbGeAlD
Fluvastatin—Hypertension—Vincristine—colon cancer	0.000486	0.00289	CcSEcCtD
Fluvastatin—Loss of consciousness—Irinotecan—colon cancer	0.000482	0.00287	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Capecitabine—colon cancer	0.000481	0.00286	CcSEcCtD
Fluvastatin—Myalgia—Vincristine—colon cancer	0.00048	0.00285	CcSEcCtD
Fluvastatin—Cough—Irinotecan—colon cancer	0.000479	0.00285	CcSEcCtD
Fluvastatin—Hypertension—Irinotecan—colon cancer	0.000474	0.00282	CcSEcCtD
Fluvastatin—Leukopenia—Fluorouracil—colon cancer	0.00047	0.0028	CcSEcCtD
Fluvastatin—Infestation NOS—Capecitabine—colon cancer	0.00047	0.00279	CcSEcCtD
Fluvastatin—Infestation—Capecitabine—colon cancer	0.00047	0.00279	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000466	0.00277	CcSEcCtD
Fluvastatin—Discomfort—Irinotecan—colon cancer	0.000462	0.00274	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Capecitabine—colon cancer	0.000461	0.00274	CcSEcCtD
Fluvastatin—Anaphylactic shock—Vincristine—colon cancer	0.00046	0.00273	CcSEcCtD
Fluvastatin—Infection—Vincristine—colon cancer	0.000457	0.00272	CcSEcCtD
Fluvastatin—Conjunctivitis—Capecitabine—colon cancer	0.000457	0.00272	CcSEcCtD
Fluvastatin—Urinary tract infection—Capecitabine—colon cancer	0.000457	0.00272	CcSEcCtD
Fluvastatin—Osteoarthritis—Methotrexate—colon cancer	0.000454	0.0027	CcSEcCtD
Fluvastatin—Confusional state—Irinotecan—colon cancer	0.000452	0.00269	CcSEcCtD
Fluvastatin—Nervous system disorder—Vincristine—colon cancer	0.000451	0.00268	CcSEcCtD
Fluvastatin—Thrombocytopenia—Vincristine—colon cancer	0.00045	0.00268	CcSEcCtD
Fluvastatin—Anaphylactic shock—Irinotecan—colon cancer	0.000448	0.00266	CcSEcCtD
Fluvastatin—Myalgia—Fluorouracil—colon cancer	0.000447	0.00266	CcSEcCtD
Fluvastatin—Chest pain—Fluorouracil—colon cancer	0.000447	0.00266	CcSEcCtD
Fluvastatin—Infection—Irinotecan—colon cancer	0.000445	0.00265	CcSEcCtD
Fluvastatin—Hyperhidrosis—Vincristine—colon cancer	0.000445	0.00264	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Capecitabine—colon cancer	0.000444	0.00264	CcSEcCtD
Fluvastatin—Discomfort—Fluorouracil—colon cancer	0.000442	0.00263	CcSEcCtD
Fluvastatin—Shock—Irinotecan—colon cancer	0.000441	0.00262	CcSEcCtD
Fluvastatin—Nervous system disorder—Irinotecan—colon cancer	0.000439	0.00261	CcSEcCtD
Fluvastatin—Thrombocytopenia—Irinotecan—colon cancer	0.000439	0.00261	CcSEcCtD
Fluvastatin—Anorexia—Vincristine—colon cancer	0.000438	0.00261	CcSEcCtD
Fluvastatin—Hyperhidrosis—Irinotecan—colon cancer	0.000433	0.00257	CcSEcCtD
Fluvastatin—Confusional state—Fluorouracil—colon cancer	0.000433	0.00257	CcSEcCtD
Fluvastatin—Anaphylactic shock—Fluorouracil—colon cancer	0.000429	0.00255	CcSEcCtD
Fluvastatin—Anorexia—Irinotecan—colon cancer	0.000427	0.00254	CcSEcCtD
Fluvastatin—Infection—Fluorouracil—colon cancer	0.000426	0.00253	CcSEcCtD
Fluvastatin—Rhinitis—Capecitabine—colon cancer	0.000423	0.00252	CcSEcCtD
Fluvastatin—Hepatitis—Capecitabine—colon cancer	0.000422	0.00251	CcSEcCtD
Fluvastatin—Nervous system disorder—Fluorouracil—colon cancer	0.000421	0.0025	CcSEcCtD
Fluvastatin—Thrombocytopenia—Fluorouracil—colon cancer	0.00042	0.0025	CcSEcCtD
Fluvastatin—Hypoaesthesia—Capecitabine—colon cancer	0.00042	0.0025	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000419	0.00249	CcSEcCtD
Fluvastatin—Pharyngitis—Capecitabine—colon cancer	0.000419	0.00249	CcSEcCtD
Fluvastatin—Insomnia—Vincristine—colon cancer	0.000416	0.00247	CcSEcCtD
Fluvastatin—Oedema peripheral—Capecitabine—colon cancer	0.000416	0.00247	CcSEcCtD
Fluvastatin—Connective tissue disorder—Capecitabine—colon cancer	0.000415	0.00247	CcSEcCtD
Fluvastatin—Paraesthesia—Vincristine—colon cancer	0.000413	0.00246	CcSEcCtD
Fluvastatin—Breast disorder—Methotrexate—colon cancer	0.00041	0.00244	CcSEcCtD
Fluvastatin—Anorexia—Fluorouracil—colon cancer	0.000409	0.00243	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000409	0.00243	CcSEcCtD
Fluvastatin—Visual impairment—Capecitabine—colon cancer	0.000407	0.00242	CcSEcCtD
Fluvastatin—Insomnia—Irinotecan—colon cancer	0.000405	0.00241	CcSEcCtD
Fluvastatin—Paraesthesia—Irinotecan—colon cancer	0.000402	0.00239	CcSEcCtD
Fluvastatin—Decreased appetite—Vincristine—colon cancer	0.0004	0.00238	CcSEcCtD
Fluvastatin—Dyspnoea—Irinotecan—colon cancer	0.000399	0.00237	CcSEcCtD
Fluvastatin—Erythema multiforme—Capecitabine—colon cancer	0.000399	0.00237	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Vincristine—colon cancer	0.000397	0.00236	CcSEcCtD
Fluvastatin—Fatigue—Vincristine—colon cancer	0.000396	0.00236	CcSEcCtD
Fluvastatin—Dyspepsia—Irinotecan—colon cancer	0.000394	0.00234	CcSEcCtD
Fluvastatin—Pain—Vincristine—colon cancer	0.000393	0.00234	CcSEcCtD
Fluvastatin—Constipation—Vincristine—colon cancer	0.000393	0.00234	CcSEcCtD
Fluvastatin—Flushing—Capecitabine—colon cancer	0.000392	0.00233	CcSEcCtD
Fluvastatin—Cardiac disorder—Capecitabine—colon cancer	0.000392	0.00233	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000391	0.00232	CcSEcCtD
Fluvastatin—Decreased appetite—Irinotecan—colon cancer	0.000389	0.00232	CcSEcCtD
Fluvastatin—Eosinophilia—Methotrexate—colon cancer	0.000389	0.00231	CcSEcCtD
Fluvastatin—Insomnia—Fluorouracil—colon cancer	0.000388	0.00231	CcSEcCtD
Fluvastatin—CYP1A1—lymph node—colon cancer	0.000388	0.00555	CbGeAlD
Fluvastatin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000387	0.0023	CcSEcCtD
Fluvastatin—Fatigue—Irinotecan—colon cancer	0.000386	0.0023	CcSEcCtD
Fluvastatin—Paraesthesia—Fluorouracil—colon cancer	0.000385	0.00229	CcSEcCtD
Fluvastatin—Pancreatitis—Methotrexate—colon cancer	0.000385	0.00229	CcSEcCtD
Fluvastatin—Pain—Irinotecan—colon cancer	0.000383	0.00228	CcSEcCtD
Fluvastatin—Constipation—Irinotecan—colon cancer	0.000383	0.00228	CcSEcCtD
Fluvastatin—Angiopathy—Capecitabine—colon cancer	0.000383	0.00228	CcSEcCtD
Fluvastatin—Dyspnoea—Fluorouracil—colon cancer	0.000382	0.00227	CcSEcCtD
Fluvastatin—Immune system disorder—Capecitabine—colon cancer	0.000381	0.00227	CcSEcCtD
Fluvastatin—Chills—Capecitabine—colon cancer	0.000379	0.00225	CcSEcCtD
Fluvastatin—Dyspepsia—Fluorouracil—colon cancer	0.000378	0.00225	CcSEcCtD
Fluvastatin—Arrhythmia—Capecitabine—colon cancer	0.000377	0.00224	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Vincristine—colon cancer	0.000376	0.00224	CcSEcCtD
Fluvastatin—Decreased appetite—Fluorouracil—colon cancer	0.000373	0.00222	CcSEcCtD
Fluvastatin—Alopecia—Capecitabine—colon cancer	0.000373	0.00222	CcSEcCtD
Fluvastatin—CYP3A4—liver—colon cancer	0.000371	0.00531	CbGeAlD
Fluvastatin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00037	0.0022	CcSEcCtD
Fluvastatin—Mental disorder—Capecitabine—colon cancer	0.00037	0.0022	CcSEcCtD
Fluvastatin—Feeling abnormal—Irinotecan—colon cancer	0.000369	0.00219	CcSEcCtD
Fluvastatin—Erythema—Capecitabine—colon cancer	0.000367	0.00218	CcSEcCtD
Fluvastatin—Pain—Fluorouracil—colon cancer	0.000367	0.00218	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Irinotecan—colon cancer	0.000366	0.00218	CcSEcCtD
Fluvastatin—CYP2D6—liver—colon cancer	0.000365	0.00523	CbGeAlD
Fluvastatin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000365	0.00217	CcSEcCtD
Fluvastatin—Abdominal pain—Vincristine—colon cancer	0.000364	0.00216	CcSEcCtD
Fluvastatin—Body temperature increased—Vincristine—colon cancer	0.000364	0.00216	CcSEcCtD
Fluvastatin—Flatulence—Capecitabine—colon cancer	0.000362	0.00215	CcSEcCtD
Fluvastatin—Erectile dysfunction—Methotrexate—colon cancer	0.000361	0.00215	CcSEcCtD
Fluvastatin—Dysgeusia—Capecitabine—colon cancer	0.00036	0.00214	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Methotrexate—colon cancer	0.000358	0.00213	CcSEcCtD
Fluvastatin—Back pain—Capecitabine—colon cancer	0.000355	0.00211	CcSEcCtD
Fluvastatin—Body temperature increased—Irinotecan—colon cancer	0.000354	0.00211	CcSEcCtD
Fluvastatin—Abdominal pain—Irinotecan—colon cancer	0.000354	0.00211	CcSEcCtD
Fluvastatin—Feeling abnormal—Fluorouracil—colon cancer	0.000353	0.0021	CcSEcCtD
Fluvastatin—Muscle spasms—Capecitabine—colon cancer	0.000353	0.0021	CcSEcCtD
Fluvastatin—Infestation—Methotrexate—colon cancer	0.00035	0.00208	CcSEcCtD
Fluvastatin—Infestation NOS—Methotrexate—colon cancer	0.00035	0.00208	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000347	0.00206	CcSEcCtD
Fluvastatin—Tremor—Capecitabine—colon cancer	0.000344	0.00205	CcSEcCtD
Fluvastatin—Ill-defined disorder—Capecitabine—colon cancer	0.000341	0.00203	CcSEcCtD
Fluvastatin—Urticaria—Fluorouracil—colon cancer	0.000341	0.00203	CcSEcCtD
Fluvastatin—Conjunctivitis—Methotrexate—colon cancer	0.00034	0.00202	CcSEcCtD
Fluvastatin—Body temperature increased—Fluorouracil—colon cancer	0.000339	0.00202	CcSEcCtD
Fluvastatin—Hypersensitivity—Vincristine—colon cancer	0.000339	0.00201	CcSEcCtD
Fluvastatin—Sweating—Methotrexate—colon cancer	0.000335	0.00199	CcSEcCtD
Fluvastatin—Malaise—Capecitabine—colon cancer	0.000331	0.00197	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Methotrexate—colon cancer	0.000331	0.00197	CcSEcCtD
Fluvastatin—Vertigo—Capecitabine—colon cancer	0.00033	0.00196	CcSEcCtD
Fluvastatin—Hypersensitivity—Irinotecan—colon cancer	0.00033	0.00196	CcSEcCtD
Fluvastatin—Asthenia—Vincristine—colon cancer	0.00033	0.00196	CcSEcCtD
Fluvastatin—Syncope—Capecitabine—colon cancer	0.000329	0.00196	CcSEcCtD
Fluvastatin—Leukopenia—Capecitabine—colon cancer	0.000329	0.00195	CcSEcCtD
Fluvastatin—Loss of consciousness—Capecitabine—colon cancer	0.000323	0.00192	CcSEcCtD
Fluvastatin—Asthenia—Irinotecan—colon cancer	0.000321	0.00191	CcSEcCtD
Fluvastatin—Cough—Capecitabine—colon cancer	0.00032	0.00191	CcSEcCtD
Fluvastatin—Hypertension—Capecitabine—colon cancer	0.000317	0.00189	CcSEcCtD
Fluvastatin—Hypersensitivity—Fluorouracil—colon cancer	0.000316	0.00188	CcSEcCtD
Fluvastatin—Diarrhoea—Vincristine—colon cancer	0.000315	0.00187	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—colon cancer	0.000314	0.00187	CcSEcCtD
Fluvastatin—Myalgia—Capecitabine—colon cancer	0.000313	0.00186	CcSEcCtD
Fluvastatin—Chest pain—Capecitabine—colon cancer	0.000313	0.00186	CcSEcCtD
Fluvastatin—Arthralgia—Capecitabine—colon cancer	0.000313	0.00186	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—colon cancer	0.000312	0.00185	CcSEcCtD
Fluvastatin—Anxiety—Capecitabine—colon cancer	0.000312	0.00185	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000311	0.00185	CcSEcCtD
Fluvastatin—Discomfort—Capecitabine—colon cancer	0.000309	0.00184	CcSEcCtD
Fluvastatin—Diarrhoea—Irinotecan—colon cancer	0.000306	0.00182	CcSEcCtD
Fluvastatin—Dizziness—Vincristine—colon cancer	0.000304	0.00181	CcSEcCtD
Fluvastatin—Pruritus—Fluorouracil—colon cancer	0.000303	0.0018	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—colon cancer	0.000303	0.0018	CcSEcCtD
Fluvastatin—Confusional state—Capecitabine—colon cancer	0.000302	0.0018	CcSEcCtD
Fluvastatin—Infection—Capecitabine—colon cancer	0.000298	0.00177	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—colon cancer	0.000297	0.00177	CcSEcCtD
Fluvastatin—Dizziness—Irinotecan—colon cancer	0.000296	0.00176	CcSEcCtD
Fluvastatin—Shock—Capecitabine—colon cancer	0.000295	0.00175	CcSEcCtD
Fluvastatin—Nervous system disorder—Capecitabine—colon cancer	0.000294	0.00175	CcSEcCtD
Fluvastatin—Diarrhoea—Fluorouracil—colon cancer	0.000293	0.00175	CcSEcCtD
Fluvastatin—Thrombocytopenia—Capecitabine—colon cancer	0.000293	0.00175	CcSEcCtD
Fluvastatin—Vomiting—Vincristine—colon cancer	0.000292	0.00174	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—colon cancer	0.000291	0.00173	CcSEcCtD
Fluvastatin—Skin disorder—Capecitabine—colon cancer	0.000291	0.00173	CcSEcCtD
Fluvastatin—Rash—Vincristine—colon cancer	0.00029	0.00172	CcSEcCtD
Fluvastatin—Hyperhidrosis—Capecitabine—colon cancer	0.00029	0.00172	CcSEcCtD
Fluvastatin—Dermatitis—Vincristine—colon cancer	0.00029	0.00172	CcSEcCtD
Fluvastatin—Headache—Vincristine—colon cancer	0.000288	0.00171	CcSEcCtD
Fluvastatin—Anorexia—Capecitabine—colon cancer	0.000286	0.0017	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—colon cancer	0.000285	0.00169	CcSEcCtD
Fluvastatin—Vomiting—Irinotecan—colon cancer	0.000285	0.00169	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—colon cancer	0.000284	0.00169	CcSEcCtD
Fluvastatin—Dizziness—Fluorouracil—colon cancer	0.000284	0.00169	CcSEcCtD
Fluvastatin—Rash—Irinotecan—colon cancer	0.000282	0.00168	CcSEcCtD
Fluvastatin—Dermatitis—Irinotecan—colon cancer	0.000282	0.00168	CcSEcCtD
Fluvastatin—Chills—Methotrexate—colon cancer	0.000282	0.00168	CcSEcCtD
Fluvastatin—Headache—Irinotecan—colon cancer	0.000281	0.00167	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—colon cancer	0.000278	0.00165	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—colon cancer	0.000275	0.00164	CcSEcCtD
Fluvastatin—Erythema—Methotrexate—colon cancer	0.000273	0.00163	CcSEcCtD
Fluvastatin—Nausea—Vincristine—colon cancer	0.000273	0.00162	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000273	0.00162	CcSEcCtD
Fluvastatin—Vomiting—Fluorouracil—colon cancer	0.000273	0.00162	CcSEcCtD
Fluvastatin—Insomnia—Capecitabine—colon cancer	0.000271	0.00161	CcSEcCtD
Fluvastatin—Rash—Fluorouracil—colon cancer	0.00027	0.00161	CcSEcCtD
Fluvastatin—Dermatitis—Fluorouracil—colon cancer	0.00027	0.00161	CcSEcCtD
Fluvastatin—Paraesthesia—Capecitabine—colon cancer	0.000269	0.0016	CcSEcCtD
Fluvastatin—Headache—Fluorouracil—colon cancer	0.000269	0.0016	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—colon cancer	0.000268	0.00159	CcSEcCtD
Fluvastatin—Dyspnoea—Capecitabine—colon cancer	0.000267	0.00159	CcSEcCtD
Fluvastatin—Nausea—Irinotecan—colon cancer	0.000266	0.00158	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—colon cancer	0.000264	0.00157	CcSEcCtD
Fluvastatin—Dyspepsia—Capecitabine—colon cancer	0.000264	0.00157	CcSEcCtD
Fluvastatin—Decreased appetite—Capecitabine—colon cancer	0.000261	0.00155	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000259	0.00154	CcSEcCtD
Fluvastatin—Fatigue—Capecitabine—colon cancer	0.000258	0.00154	CcSEcCtD
Fluvastatin—Pain—Capecitabine—colon cancer	0.000256	0.00152	CcSEcCtD
Fluvastatin—Constipation—Capecitabine—colon cancer	0.000256	0.00152	CcSEcCtD
Fluvastatin—Nausea—Fluorouracil—colon cancer	0.000255	0.00152	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—colon cancer	0.000254	0.00151	CcSEcCtD
Fluvastatin—Feeling abnormal—Capecitabine—colon cancer	0.000247	0.00147	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—colon cancer	0.000247	0.00147	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—colon cancer	0.000246	0.00146	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Capecitabine—colon cancer	0.000245	0.00146	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—colon cancer	0.000245	0.00146	CcSEcCtD
Fluvastatin—Cough—Methotrexate—colon cancer	0.000239	0.00142	CcSEcCtD
Fluvastatin—Urticaria—Capecitabine—colon cancer	0.000238	0.00142	CcSEcCtD
Fluvastatin—Abdominal pain—Capecitabine—colon cancer	0.000237	0.00141	CcSEcCtD
Fluvastatin—Body temperature increased—Capecitabine—colon cancer	0.000237	0.00141	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—colon cancer	0.000233	0.00138	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—colon cancer	0.000233	0.00138	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—colon cancer	0.000233	0.00138	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000231	0.00137	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—colon cancer	0.00023	0.00137	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—colon cancer	0.000225	0.00134	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—colon cancer	0.000223	0.00133	CcSEcCtD
Fluvastatin—Infection—Methotrexate—colon cancer	0.000222	0.00132	CcSEcCtD
Fluvastatin—Hypersensitivity—Capecitabine—colon cancer	0.000221	0.00131	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—colon cancer	0.000219	0.0013	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—colon cancer	0.000218	0.0013	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—colon cancer	0.000217	0.00129	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—colon cancer	0.000216	0.00128	CcSEcCtD
Fluvastatin—Asthenia—Capecitabine—colon cancer	0.000215	0.00128	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—colon cancer	0.000213	0.00126	CcSEcCtD
Fluvastatin—Pruritus—Capecitabine—colon cancer	0.000212	0.00126	CcSEcCtD
Fluvastatin—Diarrhoea—Capecitabine—colon cancer	0.000205	0.00122	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000203	0.00121	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—colon cancer	0.000202	0.0012	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—colon cancer	0.0002	0.00119	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—colon cancer	0.000199	0.00118	CcSEcCtD
Fluvastatin—Dizziness—Capecitabine—colon cancer	0.000198	0.00118	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—colon cancer	0.000196	0.00117	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—colon cancer	0.000194	0.00115	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000193	0.00115	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—colon cancer	0.000192	0.00114	CcSEcCtD
Fluvastatin—Pain—Methotrexate—colon cancer	0.000191	0.00113	CcSEcCtD
Fluvastatin—Vomiting—Capecitabine—colon cancer	0.000191	0.00113	CcSEcCtD
Fluvastatin—Rash—Capecitabine—colon cancer	0.000189	0.00112	CcSEcCtD
Fluvastatin—Dermatitis—Capecitabine—colon cancer	0.000189	0.00112	CcSEcCtD
Fluvastatin—Headache—Capecitabine—colon cancer	0.000188	0.00112	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—colon cancer	0.000184	0.00109	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—colon cancer	0.000182	0.00109	CcSEcCtD
Fluvastatin—Nausea—Capecitabine—colon cancer	0.000178	0.00106	CcSEcCtD
Fluvastatin—Urticaria—Methotrexate—colon cancer	0.000177	0.00105	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—colon cancer	0.000176	0.00105	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—colon cancer	0.000176	0.00105	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—colon cancer	0.000164	0.000978	CcSEcCtD
Fluvastatin—Asthenia—Methotrexate—colon cancer	0.00016	0.000952	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—colon cancer	0.000158	0.000939	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—colon cancer	0.000153	0.000908	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—colon cancer	0.000148	0.000877	CcSEcCtD
Fluvastatin—HMGCR—AMPK Signaling—TP53—colon cancer	0.000143	0.00347	CbGpPWpGaD
Fluvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000142	0.00345	CbGpPWpGaD
Fluvastatin—Vomiting—Methotrexate—colon cancer	0.000142	0.000844	CcSEcCtD
Fluvastatin—Rash—Methotrexate—colon cancer	0.000141	0.000837	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—colon cancer	0.000141	0.000836	CcSEcCtD
Fluvastatin—Headache—Methotrexate—colon cancer	0.00014	0.000831	CcSEcCtD
Fluvastatin—HMGCR—PPARA activates gene expression—EP300—colon cancer	0.000138	0.00334	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—CHST5—colon cancer	0.000137	0.00332	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—ODC1—colon cancer	0.000137	0.00332	CbGpPWpGaD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000136	0.00329	CbGpPWpGaD
Fluvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000135	0.00327	CbGpPWpGaD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000133	0.00322	CbGpPWpGaD
Fluvastatin—Nausea—Methotrexate—colon cancer	0.000133	0.000788	CcSEcCtD
Fluvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00013	0.00316	CbGpPWpGaD
Fluvastatin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000129	0.00314	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CA7—colon cancer	0.000127	0.00309	CbGpPWpGaD
Fluvastatin—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000126	0.00305	CbGpPWpGaD
Fluvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000123	0.00299	CbGpPWpGaD
Fluvastatin—HMGCR—AMPK Signaling—AKT1—colon cancer	0.000121	0.00293	CbGpPWpGaD
Fluvastatin—HMGCR—SREBP signalling—AKT1—colon cancer	0.000121	0.00293	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000119	0.0029	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.000119	0.00288	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CA7—colon cancer	0.000117	0.00283	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000116	0.00282	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000115	0.00279	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—ODC1—colon cancer	0.000112	0.00271	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—CHST5—colon cancer	0.000112	0.00271	CbGpPWpGaD
Fluvastatin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000111	0.0027	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.000108	0.00261	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000107	0.00259	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—ODC1—colon cancer	0.000105	0.00255	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CHST5—colon cancer	0.000105	0.00255	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000101	0.00246	CbGpPWpGaD
Fluvastatin—CYP1A1—Arachidonic acid metabolism—PTGS2—colon cancer	0.000101	0.00244	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CHST5—colon cancer	9.5e-05	0.0023	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—ODC1—colon cancer	9.5e-05	0.0023	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	9.41e-05	0.00228	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—colon cancer	9.32e-05	0.00226	CbGpPWpGaD
Fluvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	9.3e-05	0.00225	CbGpPWpGaD
Fluvastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	9.24e-05	0.00224	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—colon cancer	9.12e-05	0.00221	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	8.96e-05	0.00217	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—colon cancer	8.96e-05	0.00217	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	8.71e-05	0.00211	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—SRC—colon cancer	8.71e-05	0.00211	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—KRAS—colon cancer	8.61e-05	0.00209	CbGpPWpGaD
Fluvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	8.58e-05	0.00208	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	8.48e-05	0.00206	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	8.38e-05	0.00203	CbGpPWpGaD
Fluvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	8.24e-05	0.002	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CA7—colon cancer	7.92e-05	0.00192	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—colon cancer	7.81e-05	0.00189	CbGpPWpGaD
Fluvastatin—UGT1A3—NRF2 pathway—TGFB1—colon cancer	7.79e-05	0.00189	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	7.79e-05	0.00189	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CA7—colon cancer	7.75e-05	0.00188	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CHST5—colon cancer	7.72e-05	0.00187	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—ODC1—colon cancer	7.72e-05	0.00187	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—colon cancer	7.66e-05	0.00186	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	7.63e-05	0.00185	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	7.63e-05	0.00185	CbGpPWpGaD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—colon cancer	7.61e-05	0.00185	CbGpPWpGaD
Fluvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	7.52e-05	0.00182	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CA7—colon cancer	7.32e-05	0.00177	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	7.21e-05	0.00175	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ODC1—colon cancer	7.07e-05	0.00172	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CHST5—colon cancer	7.07e-05	0.00172	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	6.87e-05	0.00167	CbGpPWpGaD
Fluvastatin—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	6.82e-05	0.00165	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CA7—colon cancer	6.71e-05	0.00163	CbGpPWpGaD
Fluvastatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	6.67e-05	0.00162	CbGpPWpGaD
Fluvastatin—UGT2B7—NRF2 pathway—TGFB1—colon cancer	6.62e-05	0.00161	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—colon cancer	6.47e-05	0.00157	CbGpPWpGaD
Fluvastatin—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	6.42e-05	0.00156	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	6.13e-05	0.00149	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	6e-05	0.00146	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CA7—colon cancer	5.99e-05	0.00145	CbGpPWpGaD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	5.94e-05	0.00144	CbGpPWpGaD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—ABCB1—colon cancer	5.91e-05	0.00143	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	5.71e-05	0.00139	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	5.71e-05	0.00139	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.66e-05	0.00137	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	5.55e-05	0.00135	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	5.55e-05	0.00135	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CA7—colon cancer	5.51e-05	0.00134	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CA7—colon cancer	5.46e-05	0.00132	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	5.41e-05	0.00131	CbGpPWpGaD
Fluvastatin—UGT1A1—NRF2 pathway—TGFB1—colon cancer	5.38e-05	0.00131	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	5.34e-05	0.0013	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	4.98e-05	0.00121	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	4.96e-05	0.0012	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	4.87e-05	0.00118	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	4.87e-05	0.00118	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ODC1—colon cancer	4.8e-05	0.00116	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CHST5—colon cancer	4.8e-05	0.00116	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ODC1—colon cancer	4.69e-05	0.00114	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CHST5—colon cancer	4.69e-05	0.00114	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CA7—colon cancer	4.67e-05	0.00113	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	4.6e-05	0.00112	CbGpPWpGaD
Fluvastatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	4.6e-05	0.00111	CbGpPWpGaD
Fluvastatin—CYP1A1—PPARA activates gene expression—EP300—colon cancer	4.46e-05	0.00108	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.45e-05	0.00108	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ODC1—colon cancer	4.43e-05	0.00108	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CHST5—colon cancer	4.43e-05	0.00108	CbGpPWpGaD
Fluvastatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	4.36e-05	0.00106	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.35e-05	0.00105	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ODC1—colon cancer	4.06e-05	0.000986	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CHST5—colon cancer	4.06e-05	0.000986	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.99e-05	0.000968	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	3.91e-05	0.000948	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.7e-05	0.000898	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ODC1—colon cancer	3.63e-05	0.00088	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CHST5—colon cancer	3.63e-05	0.00088	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—ABCB1—colon cancer	3.62e-05	0.000878	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CA7—colon cancer	3.6e-05	0.000873	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—TYMS—colon cancer	3.56e-05	0.000863	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.42e-05	0.000829	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ODC1—colon cancer	3.34e-05	0.000809	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CHST5—colon cancer	3.34e-05	0.000809	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ODC1—colon cancer	3.31e-05	0.000802	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CHST5—colon cancer	3.31e-05	0.000802	CbGpPWpGaD
Fluvastatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	3.01e-05	0.000729	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—ABCB1—colon cancer	2.95e-05	0.000716	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.92e-05	0.000708	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—TYMS—colon cancer	2.9e-05	0.000703	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.84e-05	0.00069	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CHST5—colon cancer	2.83e-05	0.000686	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ODC1—colon cancer	2.83e-05	0.000686	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—ABCB1—colon cancer	2.78e-05	0.000675	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.74e-05	0.000664	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—TYMS—colon cancer	2.73e-05	0.000663	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PPARG—colon cancer	2.52e-05	0.000611	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—ABCB1—colon cancer	2.51e-05	0.000609	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—TYMS—colon cancer	2.47e-05	0.000598	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.3e-05	0.000557	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CHST5—colon cancer	2.18e-05	0.000529	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ODC1—colon cancer	2.18e-05	0.000529	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.1e-05	0.00051	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PPARG—colon cancer	2.05e-05	0.000498	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—ABCB1—colon cancer	2.04e-05	0.000495	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—TYMS—colon cancer	2e-05	0.000486	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PTGS2—colon cancer	1.98e-05	0.000481	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PPARG—colon cancer	1.94e-05	0.000469	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.91e-05	0.000463	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ABCB1—colon cancer	1.87e-05	0.000453	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—TYMS—colon cancer	1.84e-05	0.000445	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.83e-05	0.000444	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PPARG—colon cancer	1.75e-05	0.000424	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.68e-05	0.000407	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—EP300—colon cancer	1.65e-05	0.0004	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PTGS2—colon cancer	1.62e-05	0.000392	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PTGS2—colon cancer	1.52e-05	0.000369	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.5e-05	0.000363	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.44e-05	0.000349	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PPARG—colon cancer	1.42e-05	0.000344	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.41e-05	0.000343	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTGS2—colon cancer	1.37e-05	0.000333	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.37e-05	0.000331	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—EP300—colon cancer	1.34e-05	0.000326	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.32e-05	0.00032	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PPARG—colon cancer	1.3e-05	0.000315	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ABCB1—colon cancer	1.27e-05	0.000308	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—EP300—colon cancer	1.27e-05	0.000307	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—TYMS—colon cancer	1.25e-05	0.000302	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ABCB1—colon cancer	1.24e-05	0.000301	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PIK3CA—colon cancer	1.22e-05	0.000296	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—TYMS—colon cancer	1.22e-05	0.000295	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.2e-05	0.00029	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.18e-05	0.000286	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ABCB1—colon cancer	1.17e-05	0.000284	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.17e-05	0.000283	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—TYMS—colon cancer	1.15e-05	0.000279	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—EP300—colon cancer	1.14e-05	0.000277	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTGS2—colon cancer	1.12e-05	0.000271	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.1e-05	0.000266	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.07e-05	0.000261	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ABCB1—colon cancer	1.07e-05	0.000261	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—TYMS—colon cancer	1.05e-05	0.000256	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTGS2—colon cancer	1.02e-05	0.000248	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—AKT1—colon cancer	9.96e-06	0.000242	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PIK3CA—colon cancer	9.94e-06	0.000241	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.8e-06	0.000238	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ABCB1—colon cancer	9.59e-06	0.000233	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—TYMS—colon cancer	9.42e-06	0.000228	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PIK3CA—colon cancer	9.37e-06	0.000227	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—EP300—colon cancer	9.29e-06	0.000225	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.18e-06	0.000223	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.94e-06	0.000217	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.86e-06	0.000215	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PPARG—colon cancer	8.83e-06	0.000214	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ABCB1—colon cancer	8.82e-06	0.000214	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ABCB1—colon cancer	8.74e-06	0.000212	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—TYMS—colon cancer	8.66e-06	0.00021	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PPARG—colon cancer	8.63e-06	0.000209	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—TYMS—colon cancer	8.59e-06	0.000208	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—EP300—colon cancer	8.51e-06	0.000206	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PIK3CA—colon cancer	8.45e-06	0.000205	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PPARG—colon cancer	8.15e-06	0.000198	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.12e-06	0.000197	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—AKT1—colon cancer	8.12e-06	0.000197	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—AKT1—colon cancer	7.65e-06	0.000186	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.64e-06	0.000185	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PPARG—colon cancer	7.47e-06	0.000181	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ABCB1—colon cancer	7.47e-06	0.000181	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—TYMS—colon cancer	7.34e-06	0.000178	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.25e-06	0.000176	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTGS2—colon cancer	6.94e-06	0.000168	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—AKT1—colon cancer	6.91e-06	0.000167	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CA—colon cancer	6.87e-06	0.000167	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTGS2—colon cancer	6.79e-06	0.000165	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PPARG—colon cancer	6.67e-06	0.000162	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.61e-06	0.00016	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTGS2—colon cancer	6.41e-06	0.000156	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CA—colon cancer	6.29e-06	0.000153	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PPARG—colon cancer	6.14e-06	0.000149	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PPARG—colon cancer	6.08e-06	0.000148	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTGS2—colon cancer	5.88e-06	0.000143	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—EP300—colon cancer	5.78e-06	0.00014	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ABCB1—colon cancer	5.77e-06	0.00014	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—TYMS—colon cancer	5.66e-06	0.000137	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.65e-06	0.000137	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—EP300—colon cancer	5.65e-06	0.000137	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—AKT1—colon cancer	5.61e-06	0.000136	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—EP300—colon cancer	5.33e-06	0.000129	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTGS2—colon cancer	5.25e-06	0.000127	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PPARG—colon cancer	5.2e-06	0.000126	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—AKT1—colon cancer	5.14e-06	0.000125	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—EP300—colon cancer	4.89e-06	0.000119	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTGS2—colon cancer	4.83e-06	0.000117	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTGS2—colon cancer	4.78e-06	0.000116	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—EP300—colon cancer	4.36e-06	0.000106	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CA—colon cancer	4.27e-06	0.000104	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CA—colon cancer	4.18e-06	0.000101	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTGS2—colon cancer	4.09e-06	9.92e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—EP300—colon cancer	4.01e-06	9.74e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PPARG—colon cancer	4.01e-06	9.73e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—EP300—colon cancer	3.98e-06	9.65e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CA—colon cancer	3.95e-06	9.57e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CA—colon cancer	3.62e-06	8.77e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—AKT1—colon cancer	3.49e-06	8.46e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—AKT1—colon cancer	3.41e-06	8.27e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—EP300—colon cancer	3.4e-06	8.25e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CA—colon cancer	3.23e-06	7.83e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—AKT1—colon cancer	3.22e-06	7.82e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTGS2—colon cancer	3.16e-06	7.65e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CA—colon cancer	2.97e-06	7.2e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—AKT1—colon cancer	2.95e-06	7.17e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CA—colon cancer	2.94e-06	7.14e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—AKT1—colon cancer	2.64e-06	6.4e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—EP300—colon cancer	2.62e-06	6.36e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CA—colon cancer	2.52e-06	6.1e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—AKT1—colon cancer	2.43e-06	5.88e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—AKT1—colon cancer	2.4e-06	5.83e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—AKT1—colon cancer	2.05e-06	4.98e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CA—colon cancer	1.94e-06	4.71e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—AKT1—colon cancer	1.59e-06	3.85e-05	CbGpPWpGaD
